Medmain Speaks

How it started? According to global cancer statistics, stomach and colon cancers are amongst the most common leading causes of cancer deaths in the world, with stomach cancer ranking fourth in men and seventh in women, and colon cancer ranking third in men and second in women. Histopathological classification of gastric and colonic epithelial tumours is one of the routine pathological diagnosis tasks for pathologists. Computational pathology techniques based on Artificial intelligence (AI) would be of high benefit in easing the ever increasing workloads on pathologists, especially in regions that have shortages in access to pathological diagnosis services.

Medmain Inc. and Kyushu Daigaku Kigyobu (a startup activity club of Kyushu University) were together awarded the Minister of Education, Culture, Sports, Science and Technology’s award of the 2nd ” Japan Open Innovation Prize “.

My name is Daiki, I work in recruitment and PR team at Medmain Inc. The member that we feature today in “ Medmain Speaks” is Takahiro Yamazaki from the sales team. Before joining Medmain, Takahiro was working as a medical representative at one of the major Japanese pharmaceutical companies. “What made him to be interested in the medical industry in the first place?” “What’s behind his decision to move from a pharmaceutical company to an IT startup?

【Focus on the “Medmainer”-Leona Shinkai】Today, let us introduce one of our members from the sales team. What made her, who has international background join Medmain?

We are delighted to share that our manuscript entitled “Deep learning models for histopathological classification of gastric and colonic epithelial tumours” by Koji Arihiro M.D., Ph.D. and Kei Kato from Hiroshima University along with Medmain members Osamu Iizuka, Fahdi Kanavati, Michael Rambeau, Masayuki Tsuneki, was published in authoritative Scientific Reports, a journal of the Nature Research on Jan 30th.